| 0 |
CD20-directed Cytolytic Antibody [EPC] |
242 |
| 1 |
Corticosteroid [EPC] |
73 |
| 2 |
Alkylating Drug [EPC] |
39 |
| 3 |
Tumor Necrosis Factor Blocker [EPC] |
19 |
| 4 |
Atypical Antipsychotic [EPC] |
16 |
| 5 |
Folate Analog Metabolic Inhibitor [EPC] |
13 |
| 6 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
8 |
| 7 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
6 |
| 8 |
Purine Antimetabolite [EPC] |
6 |
| 9 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
6 |
| 10 |
Antirheumatic Agent [EPC] |
5 |
| 11 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
5 |
| 12 |
Platinum-based Drug [EPC] |
5 |
| 13 |
Anti-epileptic Agent [EPC] |
4 |
| 14 |
Interleukin-23 Antagonist [EPC] |
4 |
| 15 |
Mood Stabilizer [EPC] |
4 |
| 16 |
Selective T Cell Costimulation Modulator [EPC] |
4 |
| 17 |
Integrin Receptor Antagonist [EPC] |
3 |
| 18 |
Interleukin-17A Antagonist [EPC] |
3 |
| 19 |
Janus Kinase Inhibitor [EPC] |
3 |
| 20 |
Kinase Inhibitor [EPC] |
3 |
| 21 |
Provitamin D2 Compound [EPC] |
3 |
| 22 |
Thalidomide Analog [EPC] |
3 |
| 23 |
Acetylcholine Release Inhibitor [EPC] |
2 |
| 24 |
Aminosalicylate [EPC] |
2 |
| 25 |
Antimetabolite Immunosuppressant [EPC] |
2 |
| 26 |
BCL-2 Inhibitor [EPC] |
2 |
| 27 |
Complement Inhibitor [EPC] |
2 |
| 28 |
Dopamine-2 Receptor Antagonist [EPC] |
2 |
| 29 |
Factor Xa Inhibitor [EPC] |
2 |
| 30 |
GLP-1 Receptor Agonist [EPC] |
2 |
| 31 |
Interleukin-6 Receptor Antagonist [EPC] |
2 |
| 32 |
Neuromuscular Blocker [EPC] |
2 |
| 33 |
Nucleoside Metabolic Inhibitor [EPC] |
2 |
| 34 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
2 |
| 35 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
| 36 |
Anti-IgE [EPC] |
1 |
| 37 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1 |
| 38 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
| 39 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
| 40 |
Calcium Channel Blocker [EPC] |
1 |
| 41 |
Catecholamine [EPC] |
1 |
| 42 |
Chemokine Receptor Type 4 Interaction [EPC] |
1 |
| 43 |
Dihydropyridine Calcium Channel Blocker [EPC] |
1 |
| 44 |
Fluoroquinolone Antibacterial [EPC] |
1 |
| 45 |
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] |
1 |
| 46 |
HMG-CoA Reductase Inhibitor [EPC] |
1 |
| 47 |
Hedgehog Pathway Inhibitor [EPC] |
1 |
| 48 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
| 49 |
Human Immunoglobulin G [EPC] |
1 |
| 50 |
Insulin Analog [EPC] |
1 |
| 51 |
Interleukin-1 Receptor Antagonist [EPC] |
1 |
| 52 |
Interleukin-12 Antagonist [EPC] |
1 |
| 53 |
Interleukin-17 Receptor A Antagonist [EPC] |
1 |
| 54 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
1 |
| 55 |
Interleukin-5 Antagonist [EPC] |
1 |
| 56 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
1 |
| 57 |
Loop Diuretic [EPC] |
1 |
| 58 |
Macrolide Antimicrobial [EPC] |
1 |
| 59 |
Monoclonal Antibody [EPC] |
1 |
| 60 |
Opioid Agonist [EPC] |
1 |
| 61 |
Penem Antibacterial [EPC] |
1 |
| 62 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
| 63 |
Platelet Aggregation Inhibitor [EPC] |
1 |
| 64 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
| 65 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
1 |
| 66 |
Survival of Motor Neuron 2 Splicing Modifier [EPC] |
1 |
| 67 |
Topoisomerase Inhibitor [EPC] |
1 |
| 68 |
alpha-Adrenergic Agonist [EPC] |
1 |
| 69 |
beta-Adrenergic Agonist [EPC] |
1 |
| 70 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
| 71 |
mTOR Inhibitor Immunosuppressant [EPC] |
1 |